ProQuest Investments IV, L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ProQuest Investments IV, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ProQuest Investments IV, L.P.. ProQuest Investments IV, L.P. is a 10% Owner in EAGLE PHARMACEUTICALS, INC. ($EGRX) and a 10% Owner in Immune Design Corp. ($IMDZ) and a 10% Owner in UroGen Pharma Ltd. ($URGN).
Address: 90 NASSAU STREET, 5TH FLOOR PRINCETON 08542-4520 NJ
Companies in which ProQuest Investments IV, L.P. is an Insider
EAGLE PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ProQuest Investments IV, L.P.: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2017
$EGRX Market Capitalization: $1.09B
$EGRX Previous Close: $69.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMMUNE DESIGN CORP.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ProQuest Investments IV, L.P.: 10% Owner
Holdings: 1,983,858 shares
Current Value: $10,514,447
Latest Transaction: May 13 2015
$IMDZ Market Capitalization: $132.13M
$IMDZ Previous Close: $5.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
UroGen Pharma Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ProQuest Investments IV, L.P.: 10% Owner
Holdings: 1,419,838 shares
Latest Transaction: Nov 29 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ProQuest Investments IV, L.P.
Sentiment: All, EGRX, IMDZ, URGN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29 2017 | URGN | UroGen Pharma Ltd. | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 40.51 | 177,807 | 7,202,962 | 1,242,031 | 1.4 M to 1.2 M (-12.52 %) |
| Nov 29 2017 | URGN | UroGen Pharma Ltd. | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 41.12 | 31,491 | 1,294,910 | 1,419,838 | 1.5 M to 1.4 M (-2.17 %) |
| May 15 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Buy | J | 0.00 | 149,107 | 0 | 149,107 | 0 to 149.1 K |
| May 15 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Buy | J | 0.00 | 149,107 | 0 | 172,381 | 23.3 K to 172.4 K (+640.66 %) |
| May 15 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | J | 0.00 | 3,584,087 | 0 | 0 | 3.6 M to 0 (-100.00 %) |
| Apr 03 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.13 | 61,420 | 5,105,845 | 3,584,087 | 3.6 M to 3.6 M (-1.68 %) |
| Apr 03 2017 | EGRX | EAGLE PHARMACEUTIC ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 83.02 | 23,689 | 1,966,661 | 3,645,507 | 3.7 M to 3.6 M (-0.65 %) |
View all ProQuest Investments IV, L.P. insider transactions.